Bill & Melinda Gates Foundation
Keith Klugman, director for pneumonia, leads the Bill & Melinda Gates Foundation’s work to improve the development and delivery of pneumonia vaccines and expand the use of antibiotic treatments and diagnostic tools.
Keith is a leading expert on antibiotic resistance in pneumonia pathogens and helped develop the pneumococcal vaccine that is now part of the immunization regimen for children born in the United States and is being rolled out globally. Keith was the William H. Foege Professor of Global Health and Professor of Epidemiology in the Rollins School of Public Health at Emory University as well as Professor of Medicine in the Division of Infectious Diseases at the Emory School of Medicine. In addition, he still serves as Honorary Professor in the Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand in South Africa.
Keith has chaired or served on numerous expert committees for the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), among other American and international organizations, and has published more than 450 scientific papers on the subjects of pneumonia, meningitis, antimicrobial resistance, and vaccines for bacterial pathogens, which have been cited more than 20,000 times to date. He is currently the President of the International Society for Infectious Diseases.
Keith trained in South Africa and did his post-doctoral research at Rockefeller University in New York.